This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| ICD-10 | M45.2 |
| Synonyms / related terms | Ankylosing spondylitis with cervical spine involvement, AS with cervical myelopathy, cervical AS |
| Special Copayment Reduction | V140 — Severe intractable disease (copayment 10%, 5 years) |
| Main age of onset | Onset at ages 15-35; cervical involvement mainly appears in patients with long-standing disease |
Contents
| s1 | History |
| s2 | Causes |
| s3 | Genetics |
| s4 | General epidemiology |
| s5 | Pathophysiology |
| s6 | Symptoms |
| s7 | Signs |
| s8 | Screening |
| s9 | Diagnosis |
| s10 | Treatment |
| s11 | Prognosis |
| s12 | Prevention |
| s13 | References |
Cervical spine (C3-C7) involvement in ankylosing spondylitis (AS) is a major stage that follows lumbar and sacroiliac joint involvement in the natural course of AS, and it is important because of the clinical risk of cervical myelopathy. Historically, as cervical radiographic findings in AS patients were systematically described in the 1960s-70s, features such as cervical discitis, facet joint ankylosis, and syndesmophytes were established. With the introduction of CT and MRI from the 1980s onward, detailed evaluation of cervical spinal cord compression, spinal cord signal abnormalities, and incomplete syndesmophytes became possible. When cervical myelopathy occurs in AS patients with cervical involvement, clinical outcomes are poor and the risk of perioperative complications is high, so a multidisciplinary approach involving anesthesiology, neurosurgery, and rheumatology is essential. Since the 2010s, evaluation of active inflammation using cervical MRI and anti-TNF treatment have begun to be integrated into the management of cervical involvement.
The causes of cervical AS share the risk factors of systemic AS. HLA-B27 positivity, long disease duration, inadequate treatment, and smoking are the main risk factors. The cervical spine has a large range of motion and is subject to repetitive mechanical loading, and enthesis stress promotes ossification of the anterior and posterior longitudinal ligaments, joint capsules, and ligamentum flavum. Cervical discitis is characteristic of early cervical involvement in AS, with autoimmune disc destruction followed by reactive bony fusion. Osteoporotic bone can cause cervical fractures even with minor trauma, and in a cervical spine with bony fusion in particular, stress concentrated at the fracture site raises the fracture risk. Loss of normal shock-absorbing function in the contracted cervical spine, so that external force is transmitted directly to the spinal cord, is also a mechanism of spinal cord injury risk.
The genetic basis of cervical AS, as in M45.0, centers on HLA-B27 (especially B*27:04, B*27:05), IL23R, and ERAP1. Cervical-specific genetic association studies are lacking, but polymorphisms of ossification-related genes such as MMP-3, CTGF, and BMP-2 may affect the extent of cervical ligament ossification. Ossification of the posterior longitudinal ligament (OPLL) occurs frequently in East Asians independently of AS, and when AS and OPLL coexist, the risk of cervical myelopathy increases markedly. Osteoporosis-related genetic factors (ESR1, LRP5, RANK/RANKL) also contribute to the genetic background of cervical fracture risk. Familial clustering of AS suggests the importance of genetic predisposition, and similarity in the pattern of cervical involvement within families has also been reported.
The prevalence of clinically significant cervical involvement in AS reaches about 50-70% with an AS disease duration of 10 years or more, and radiographic evidence of bony fusion appears in a higher proportion. Cervical myelopathy is reported to occur in about 2-5% of AS patients. Cervical fractures account for 15-30% of all fractures in AS, a markedly higher frequency than in the non-osteoporotic general population. Male sex, older age, cervical ankylosis predominantly in the coronal plane of motion, and low DEXA bone mineral density are risk factors for cervical fracture. Epidemiologic data on cervical involvement in AS in Korea are lacking, but in East Asian cohorts the frequency of coexisting OPLL is higher than in the West, so the risk of cervical myelopathy may be relatively greater.
The pathology of cervical AS begins with enthesitis of the C3-C7 zygapophyseal (facet) joints, the disc-vertebral junction, the anterior and posterior longitudinal ligaments, and the interspinous ligaments. TNF-α- and IL-17A-mediated inflammation destroys the fibrocartilage at ligament attachment sites, and activation of BMP/Wnt signaling forms reactive syndesmophytes (osteophyte-like bridging). Through repeated inflammation-repair cycles, discitis (pseudoarthrosis or Anderson lesion) occurs, and segmental bony fusion eventually results. A segment with complete bony fusion places excessive stress on adjacent segments through a long lever arm effect, causing additional damage. Cervical spinal canal stenosis arises from ossification of the posterior longitudinal ligament, facet joint hypertrophy, and hypertrophy and ossification of the ligamentum flavum, causing spinal cord ischemia and compression.
The characteristic symptoms of cervical AS are cervical pain (inflammatory pain of the cervical ligaments and muscles) and a gradual decrease in cervical range of motion. Early on, morning stiffness is prominent and shows an inflammatory pattern that improves with exercise. With progression, cervical flexion, extension, and rotation become restricted in sequence, and because of the fixed cervical posture (rigid posture), looking forward and checking behind become impossible. Cervical radiculopathy manifests as radiating pain, paresthesia, and weakness of the related muscles in the C5-C7 nerve root distribution. Cervical myelopathy presents with progressive upper and lower limb weakness, gait disturbance (spastic gait), reduced hand function (clumsiness of the hands), and bladder and bowel dysfunction, and because symptoms are mild at first, it is easily overlooked. Cervical fracture may present with sudden worsening of neck pain and the onset of neurological symptoms, and immediate evaluation is needed after a fall or a traffic accident.
On physical examination, cervical range of motion (flexion, extension, rotation, lateral bending) is measured with a goniometer or standard clinical measurement methods. The occiput-to-wall distance and the chin-brow-vertical angle (CBVA) are used to quantify the degree of cervical flexion contracture. On neurological examination, abnormalities of upper limb deep tendon reflexes (biceps, triceps, brachioradialis), Hoffmann sign, paresthesia, and intrinsic muscle weakness are checked. When myelopathy is suspected, lower limb hyperreflexia, Babinski sign, and gait testing (tandem walk) are performed. The cervical compression test (Spurling test) is used to provoke or reproduce radiculopathy, but is applied with caution when severe ankylosis or instability is suspected. The mJOA (modified Japanese Orthopaedic Association) score is used to assess the severity of cervical myelopathy.
For screening of cervical AS, anteroposterior and lateral cervical radiographs are performed regularly to assess syndesmophytes, discitis, and the degree of bony fusion. MRI (cervical, T2/STIR) is essential for identifying active inflammation, spinal cord compression, and spinal cord signal abnormalities (increased T2). CT is used to evaluate bony anatomy, the extent of OPLL, the degree of bony fusion, and fractures. Nerve conduction studies/electromyography confirm the distribution of cervical radiculopathy. Spinal evoked potentials (somatosensory evoked potential, SSEP; motor evoked potential, MEP) are used for the severity of myelopathy and for intraoperative spinal cord function monitoring. Bone density measurement is needed to assess the risk of cervical fracture.
A diagnosis of cervical AS is established when, in a patient meeting the modified New York criteria for AS, characteristic AS findings in the C3-C7 region (syndesmophytes, discitis, facet joint ankylosis) are identified on cervical radiographs or MRI. Differentiation from OPLL is made by confirming the extent and morphology of posterior longitudinal ligament ossification on CT. For differentiation from cervical disc herniation and degenerative cervical spondylosis, differences in radiographic patterns are important (AS: extensive segmental involvement, enthesis involvement, discitis; degenerative: localized disc space narrowing, osteophytes). When acute neurological symptoms occur, emergency MRI and neurosurgical consultation are needed. To assess the severity of myelopathy, the mJOA score and the Nurick scale are recorded.
Drug treatment of cervical AS follows that of systemic AS; in the absence of cervical radiculopathy or myelopathy, NSAIDs, TNF inhibitors, and IL-17A inhibitors are administered. Physical therapy focuses on cervical stabilization exercises (strengthening the deep cervical flexors), posture correction, and maintenance of cervical ROM, and cervical traction is contraindicated in AS. When cervical myelopathy occurs (mJOA ≤ 14 or progressive neurological deterioration), surgical decompression (anterior cervical discectomy or posterior laminoplasty/laminectomy) and fusion are needed. For cervical fractures, conservative (rigid brace immobilization) or surgical treatment is decided according to neurological status. Under general anesthesia, tracheal intubation with a video laryngoscope or a flexible fiberoptic bronchoscope is standard, and Macintosh laryngoscope intubation requiring cervical extension is treated as nearly contraindicated.
The prognosis of AS patients who develop cervical myelopathy depends largely on the degree of spinal cord injury and the duration before surgery. In early mild myelopathy (mJOA > 14), functional recovery is possible with early surgical decompression. In moderate or worse myelopathy (mJOA ≤ 11), recovery after surgery is often incomplete. Complete quadriplegia after cervical fracture carries high acute-phase mortality, and even in survivors long-term dependence persists. Cervical AS without neurological complications can maintain function with appropriate drug treatment and exercise rehabilitation. Cervical postural deformity (chin-on-chest deformity) requires surgical correction (osteotomy) and carries a high surgical risk. Early TNF/IL-17 inhibitor administration and regular exercise can slow the rate of progression of cervical ankylosis.
Prevention of cervical AS starts with early diagnosis of systemic AS and vigorous anti-inflammatory treatment. Cervical extension exercises, deep cervical flexor strengthening exercises, and posture correction education delay cervical flexion deformity and functional decline. Fall prevention education and environmental modification (non-slip surfaces, stair handrails) are important for reducing the risk of cervical fracture. In a traffic accident, cervical hyperextension injury (whiplash) is especially fatal in a stiffened cervical spine, so education on adjusting the headrest position and wearing a seat belt while driving is needed. Osteoporosis treatment (bisphosphonates, anti-RANKL, vitamin D/calcium) is essential for reducing the risk of cervical fracture. Before surgery or anesthesia, always check for spinal cord compression with cervical radiographs and MRI.
1. van der Linden S, et al. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361-8.
2. Sieper J, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(Suppl 3):iii8-18.
3. Braun J, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896-904.
4. Poddubnyy D, et al. Rates and predictors of radiographic spinal progression in AS. Ann Rheum Dis. 2011;70(8):1369-74.
5. Baraliakos X, et al. MRI in AS: patterns of spinal changes. Rheumatology. 2017;56(3):421-32.
6. Reveille JD. Genetics of spondyloarthritis — beyond the MHC. Nat Rev Rheumatol. 2012;8(5):296-304.
7. Klingberg E, et al. Osteoporosis in ankylosing spondylitis — prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14(3):R108.
8. Ramiro S, et al. ASAS-EULAR recommendations for AS management: 2022 update. Ann Rheum Dis. 2023;82(1):19-34.
9. Kim TH, et al. Spondyloarthropathies in Korea: prevalence and clinical characteristics. J Korean Med Sci. 2021;36(12):e96.
10. Wanders AJ, et al. NSAIDs inhibit radiographic progression in AS. Arthritis Rheum. 2005;52(6):1756-65.